« Back to Directory of Resources
Treatments Under Development
Here you will find a list of current treatments under development:
| Brand Name: | Xgeva (also marketed as Prolia) |
| Generic Name: | denosumab |
| Code Name: | AMG162 |
| Company: | Amgen |
| FDA Clinical Phase: | 2 & 3 |
Description:
Prolia is a human monoclonal …
| Brand Name: | |
| Generic Name: | ridaforolimus (formerly deforolimus) |
| Code Name: | AP23573 |
| Company: | Ariad Pharmaceuticals & Merck |
| FDA Clinical Phase: | 1 |
Description:
Ridaforolimus, formerly known as deforolimus, is …
| Brand Name: | |
| Generic Name: | |
| Code Name: | AT9283 |
| Company: | Astex |
| FDA Clinical Phase: | 2 |
Description:
AT9283 is a kinase inhibitor that prevents cell division, thereby stopping …
| Brand Name: | |
| Generic Name: | |
| Code Name: | BI-505 |
| Company: | BioInvent |
| FDA Clinical Phase: | 1 |
Description:
BI-505 is a fully human antibody that causes cell death. It …
| Brand Name: | |
| Generic Name: | |
| Code Name: | BT-062 |
| Company: | Biotest |
| FDA Clinical Phase: | 1/2 |
Description:
BT-062 (news articles) …
| Brand Name: | Atiprimod |
| Generic Name: | azaspirane |
| Code Name: | SK&F106615 |
| Company: | Callisto Pharmaceuticals |
| FDA Clinical Phase: | 1/2 |
Description:
Atiprimod is a type of signal transduction inhibitor. It is being studied in the treatment of certain multiple myelomas and